UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049323
Receipt number R000056170
Scientific Title Effect of bathing method using bath preparation containing rice extract on pruritus in patients receiving hemodialysis
Date of disclosure of the study information 2022/10/26
Last modified on 2024/05/18 01:05:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of bathing method using bath preparation containing rice extract on pruritus in patients receiving hemodialysis

Acronym

Effect of bathing method using bath preparation containing rice extract

Scientific Title

Effect of bathing method using bath preparation containing rice extract on pruritus in patients receiving hemodialysis

Scientific Title:Acronym

Effect of bathing method using bath preparation containing rice extract

Region

Japan


Condition

Condition

End stage kidney disease

Classification by specialty

Nephrology Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of bathing method using bath preparation containing rice extract on pruritus in patients receiving hemodialysis

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

VAS score of severity of pruritus after the implementation of bathing method using bath preparation containing rice extract for 4 weeks

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Use of bath preparation containing rice extract (Non-dialysis days, 4 days/week, for 4 weeks)

Interventions/Control_2

Not use of bath preparation containing rice extract (Non-dialysis days, 4 days/week, for 4 weeks)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients who are undergoing hemodialysis for at least 6 months.
2.Patients with pruritus.
3.Japanese males and females aged over 20 years old at the time of informed consent.
4.Patients who agree to participate in this study with a written informed consent after receiving sufficient explanation relating to this study.

Key exclusion criteria

1.Patients who are not allowed to take a bath by physician.
2.Patients who underwent any changes that were considered to affect the severity of pruritus (prescription of antihistamines, nalfurafine hydrochloride, topical steroids, or moisturizers, or dialysis conditions) during the study period.
3.Patients who are deemed inappropriate by the principal investigator.

Target sample size

16


Research contact person

Name of lead principal investigator

1st name Katsuya
Middle name
Last name Yamauchi

Organization

Yamauchi pharmacy

Division name

Yamauchi pharmacy

Zip code

420-0838

Address

8-7 Aioi-cho, Aoi-ku, Shizuoka 420-0838, Japan

TEL

054-200-0255

Email

rinbokukan@yahoo.co.jp


Public contact

Name of contact person

1st name Hiroshi
Middle name
Last name Suzuki

Organization

Yamauchi pharmacy

Division name

Yamauchi pharmacy

Zip code

420-0838

Address

8-7 Aioi-cho, Aoi-ku, Shizuoka 420-0838, Japan

TEL

054-200-0255

Homepage URL


Email

rinbokukan@yahoo.co.jp


Sponsor or person

Institute

Yamauchi pharmacy

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of the Tokokai medical corporation association

Address

9-5 Aioi-cho, Aoi-ku, Shizuoka 420-0838, Japan

Tel

054-247-2785

Email

hm-yamauchi@fmwbs.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 10 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

13

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events

No adverse events were observed in the participants.

Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 10 Month 21 Day

Date of IRB

2022 Year 10 Month 25 Day

Anticipated trial start date

2022 Year 10 Month 26 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry

2023 Year 12 Month 31 Day

Date trial data considered complete

2023 Year 12 Month 31 Day

Date analysis concluded

2023 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2022 Year 10 Month 26 Day

Last modified on

2024 Year 05 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056170